Theratechnologies Inc [THTX] stock prices are up 7.36% to $1.75 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The THTX shares have gain 9.38% over the last week, with a monthly amount drifted -2.78%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Theratechnologies Inc [NASDAQ: THTX] stock has seen the most recent analyst activity on November 17, 2022, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $9. Previously, Canaccord Genuity downgraded its rating to Hold on July 29, 2021, and dropped its price target to $3.
The stock price of Theratechnologies Inc [THTX] has been fluctuating between $1.08 and $2.18 over the past year. Theratechnologies Inc [NASDAQ: THTX] shares were valued at $1.75 at the most recent close of the market.
Analyzing the THTX fundamentals
The Theratechnologies Inc [NASDAQ:THTX] reported sales of 84.32M for trailing twelve months, representing a surge of 8.37%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.12%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.04%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is 0.14 and Total Capital is 0.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-2.94.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6137 points at the first support level, and at 1.4774 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9425, and for the 2nd resistance point, it is at 2.1350.
Ratios To Look Out For
It’s worth pointing out that Theratechnologies Inc [NASDAQ:THTX]’s Current Ratio is 1.08. Also, the Quick Ratio is 0.97, while the Cash Ratio stands at 0.66. Considering the valuation of this stock, the price to sales ratio is 0.50.
